Druta Alexandrina, Bouhmala Rania, Ragdi Teqwa, Luna Mariangel, Bañobre-López Manuel, Masaguer Christian F, Amorín Manuel, Barbosa Silvia, Taboada Pablo, Coelho Alberto
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Colloids and Polymers Physics Group, Department of Physics of Particles, Faculty of Physics, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Pharmaceutics. 2025 Apr 11;17(4):505. doi: 10.3390/pharmaceutics17040505.
: The isatin nucleus is a privileged scaffold in drug discovery, particularly due to its proven relevance in anticancer research. Developing reusable heterogeneous 3D catalysts for drug synthesis represents a critical challenge in both industrial and academic contexts. This multi and interdisciplinary work aimed to design and synthesize a novel 3D-printed silica-based porous catalyst functionalized with palladium, evaluate its catalytic performance in isatin drug synthesis, and assess the antiproliferative activity of the resulting compounds against tumor cell lines such as HeLa, MCF-7, and MDA-MB231. : The novel multifaceted approach to synthesizing this heterogeneous catalyst involved the surface growth of a metal-organic framework (ZIF-8) on 3D-printed silica support, followed by potassium silicate coating and pyrolysis. : After detailed physicochemical characterization, the catalyst was tested in challenging "double" palladium-catalyzed cross-coupling reactions (Suzuki, Stille, and Heck), demonstrating robustness, reusability, and high efficiency in producing bis-1,5-aryl, alkynyl, and alkenyl-isatin derivatives. Importantly, no leaching of palladium species was detected during the catalytic cycles, further underscoring the stability of the system. These isatin-based compounds exhibited remarkable cytotoxicity, with selective molecules achieving nanomolar potency against MCF-7 cells, surpassing reference drugs such as doxorubicin and sunitinib. : This study not only introduces a novel strategy for fabricating porous heterogeneous catalysts from sintered surfaces but also highlights new biomolecules with promising applications in cancer research.
异吲哚酮核是药物研发中一种具有优势的骨架结构,特别是因其在抗癌研究中已被证实的相关性。开发用于药物合成的可重复使用的多相3D催化剂在工业和学术领域都是一项严峻的挑战。这项多学科交叉工作旨在设计并合成一种用钯功能化的新型3D打印二氧化硅基多孔催化剂,评估其在异吲哚酮药物合成中的催化性能,并评估所得化合物对HeLa、MCF-7和MDA-MB231等肿瘤细胞系的抗增殖活性。:合成这种多相催化剂的新颖多方面方法包括在3D打印二氧化硅载体上进行金属有机框架(ZIF-8)的表面生长,随后进行硅酸钾涂层和热解。:经过详细的物理化学表征后,该催化剂在具有挑战性的“双重”钯催化交叉偶联反应(铃木反应、施蒂勒反应和赫克反应)中进行了测试,证明了其在生产双-1,5-芳基、炔基和烯基异吲哚酮衍生物方面的稳健性、可重复使用性和高效率。重要的是,在催化循环过程中未检测到钯物种的浸出,进一步强调了该体系的稳定性。这些基于异吲哚酮的化合物表现出显著的细胞毒性,一些选择性分子对MCF-7细胞的效力达到纳摩尔级别,超过了阿霉素和舒尼替尼等参考药物。:这项研究不仅介绍了一种从烧结表面制备多孔多相催化剂的新策略,还突出了在癌症研究中具有潜在应用前景的新生物分子。